Hemostasis and nanotechnology

Patrick Hangge, Jonathan Stone, Hassan Albadawi, Yu Shrike Zhang, Ali Khademhosseini, Rahmi Oklu

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Hemorrhage accounts for significant morbidity and mortality. Various techniques have been employed to augment hemostasis from simple tourniquets to self-assembling nanoparticles. A growing understanding of the natural clotting cascade has allowed agents to become more targeted for potential use in different clinical scenarios. This review discusses current and developing hemostatic techniques, including matrix agents, external agents, biologically inspired agents, and synthetic and cell-derived nanoparticles.

Original languageEnglish (US)
Pages (from-to)S267-S275
JournalCardiovascular Diagnosis and Therapy
Volume7
DOIs
StatePublished - Dec 1 2017

Fingerprint

Nanotechnology
Hemostasis
Nanoparticles
Hemostatic Techniques
Artificial Cells
Tourniquets
Hemorrhage
Morbidity
Mortality

Keywords

  • Coagulation
  • Hemostasis
  • Nanotechnology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hemostasis and nanotechnology. / Hangge, Patrick; Stone, Jonathan; Albadawi, Hassan; Zhang, Yu Shrike; Khademhosseini, Ali; Oklu, Rahmi.

In: Cardiovascular Diagnosis and Therapy, Vol. 7, 01.12.2017, p. S267-S275.

Research output: Contribution to journalReview article

Hangge, P, Stone, J, Albadawi, H, Zhang, YS, Khademhosseini, A & Oklu, R 2017, 'Hemostasis and nanotechnology', Cardiovascular Diagnosis and Therapy, vol. 7, pp. S267-S275. https://doi.org/10.21037/cdt.2017.08.07
Hangge, Patrick ; Stone, Jonathan ; Albadawi, Hassan ; Zhang, Yu Shrike ; Khademhosseini, Ali ; Oklu, Rahmi. / Hemostasis and nanotechnology. In: Cardiovascular Diagnosis and Therapy. 2017 ; Vol. 7. pp. S267-S275.
@article{871802a19e8c42b7b5e600ace08bb7a9,
title = "Hemostasis and nanotechnology",
abstract = "Hemorrhage accounts for significant morbidity and mortality. Various techniques have been employed to augment hemostasis from simple tourniquets to self-assembling nanoparticles. A growing understanding of the natural clotting cascade has allowed agents to become more targeted for potential use in different clinical scenarios. This review discusses current and developing hemostatic techniques, including matrix agents, external agents, biologically inspired agents, and synthetic and cell-derived nanoparticles.",
keywords = "Coagulation, Hemostasis, Nanotechnology",
author = "Patrick Hangge and Jonathan Stone and Hassan Albadawi and Zhang, {Yu Shrike} and Ali Khademhosseini and Rahmi Oklu",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/cdt.2017.08.07",
language = "English (US)",
volume = "7",
pages = "S267--S275",
journal = "Cardiovascular Diagnosis and Therapy",
issn = "2223-3652",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Hemostasis and nanotechnology

AU - Hangge, Patrick

AU - Stone, Jonathan

AU - Albadawi, Hassan

AU - Zhang, Yu Shrike

AU - Khademhosseini, Ali

AU - Oklu, Rahmi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Hemorrhage accounts for significant morbidity and mortality. Various techniques have been employed to augment hemostasis from simple tourniquets to self-assembling nanoparticles. A growing understanding of the natural clotting cascade has allowed agents to become more targeted for potential use in different clinical scenarios. This review discusses current and developing hemostatic techniques, including matrix agents, external agents, biologically inspired agents, and synthetic and cell-derived nanoparticles.

AB - Hemorrhage accounts for significant morbidity and mortality. Various techniques have been employed to augment hemostasis from simple tourniquets to self-assembling nanoparticles. A growing understanding of the natural clotting cascade has allowed agents to become more targeted for potential use in different clinical scenarios. This review discusses current and developing hemostatic techniques, including matrix agents, external agents, biologically inspired agents, and synthetic and cell-derived nanoparticles.

KW - Coagulation

KW - Hemostasis

KW - Nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=85038625792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038625792&partnerID=8YFLogxK

U2 - 10.21037/cdt.2017.08.07

DO - 10.21037/cdt.2017.08.07

M3 - Review article

AN - SCOPUS:85038625792

VL - 7

SP - S267-S275

JO - Cardiovascular Diagnosis and Therapy

JF - Cardiovascular Diagnosis and Therapy

SN - 2223-3652

ER -